FormDSignal
40

Aegle Therapeutics Corp raises $2.3M under Reg D

Company raise · Closed · WOBURN, MA · Form D filed 2026-08-28

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Evangelos BadiavasDirector
Scott BraunsteinDirector
Shelley HartmanExecutive Officer, Director
Leon MoulderDirector

Signed by Shelley Hartman, Chief Executive Officer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

Other filings by this issuer